GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $64.82 $75.66 Friday, 19th Apr 2024 CYTK stock ended at $67.55. This is 0.82% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $64.82 to a day high of $67.80.
90 days $61.33 $84.92
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
2023-08-09 $31.98 $32.45 $31.63 $31.80 548 358
2023-08-08 $31.33 $32.14 $31.00 $31.95 752 561
2023-08-07 $33.45 $33.45 $31.05 $31.35 932 580
2023-08-04 $31.99 $34.97 $31.95 $33.19 1 104 422
2023-08-03 $31.02 $32.27 $31.02 $31.70 1 130 146
2023-08-02 $32.01 $32.44 $30.66 $31.08 804 890
2023-08-01 $33.09 $33.09 $32.02 $32.50 760 117
2023-07-31 $33.00 $33.38 $32.87 $33.35 667 321
2023-07-28 $32.28 $33.56 $32.17 $33.25 1 253 385
2023-07-27 $32.68 $32.77 $31.92 $32.23 676 106
2023-07-26 $32.01 $32.58 $31.81 $32.40 575 645
2023-07-25 $32.65 $33.15 $32.10 $32.14 757 904
2023-07-24 $32.76 $33.17 $32.05 $32.89 439 884
2023-07-21 $32.46 $33.29 $32.26 $32.72 1 096 131
2023-07-20 $33.60 $33.68 $32.39 $32.40 913 555
2023-07-19 $33.41 $34.27 $33.35 $33.62 876 146
2023-07-18 $33.73 $33.89 $33.04 $33.19 649 715
2023-07-17 $35.18 $35.88 $33.80 $33.81 582 461
2023-07-14 $35.32 $35.39 $34.62 $34.93 625 240
2023-07-13 $35.37 $36.26 $35.08 $35.50 681 016
2023-07-12 $35.61 $35.83 $34.85 $35.29 1 043 673
2023-07-11 $35.83 $35.83 $34.92 $35.13 745 773
2023-07-10 $34.63 $36.04 $34.63 $35.85 985 349
2023-07-07 $33.68 $35.29 $33.68 $34.71 1 403 832
2023-07-06 $32.87 $33.65 $32.69 $33.63 507 265
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT